Eliminating Viral Hepatitis in Turkey: Achievements and Challenges

After the declaration Global Health Sector Strategy on Viral Hepatitis by the World Health Organization in 2016, the Turkish Government defined a national strategy covering 2018-2023 to reach goals by 2030. Following a participatory decision process and a series of workshops, the strategy was built on eight separate subheadings. Apart from the official Prevention and Control Program, two separate road maps for hepatitis B and C were developed to obtain targets accessible with the cooperation of the Viral Hepatitis Society and the Turkish Association for the Study of the Liver in 2018 and 2020, respectively. Up to 2023, achievements and the current situation of the National Viral Hepatitis Prevention and Control Program and the hepatitis B virus and hepatitis C virus road maps were assessed in detail on June 28th, 2022, by the subject matter experts in Turkey. Besides the officially reported achievement rate (42%) of the Program in 2021, participants mentioned undesirable effects of the coronavirus disease-2019 pandemic, unregulated migration, low levels of professional and public awareness, and barriers to access to anti-viral treatment. Recommendations focused on increasing the efficiency of screening and surveillance by integrating the viral carrier identity of individuals into the national health information system, simplifying the drug supplement and treatment initiation process and insisting on education to raise awareness.

[1]  R. Gish,et al.  Simplifying Treatment Criteria in Chronic Hepatitis B: Reducing Barriers to Elimination. , 2022, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[2]  Jisoo A. Kwon,et al.  Global change in hepatitis C virus prevalence and cascade of care between 2015 and 2020: a modelling study. , 2022, The lancet. Gastroenterology & hepatology.

[3]  L. Abu-Raddad,et al.  The epidemiology of hepatitis C virus in Central Asia: Systematic review, meta-analyses, and meta-regression analyses , 2019, Scientific Reports.

[4]  R. Ozturk,et al.  Seroepidemiology of Hepatitis B Virus Infection in İstanbul: A 20-year Survey , 2016 .

[5]  H. Bashour,et al.  Hepatitis B and C in the Syrian Arab Republic: a review. , 2016, Eastern Mediterranean health journal = La revue de sante de la Mediterranee orientale = al-Majallah al-sihhiyah li-sharq al-mutawassit.

[6]  U. Akarca,et al.  Seroprevalence of hepatitis B and C virus infections and risk factors in Turkey: a fieldwork TURHEP study. , 2015, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[7]  B. Cowie,et al.  Hepatitis B virus epidemiology. , 2015, Cold Spring Harbor perspectives in medicine.

[8]  G. Borsboom,et al.  Age- and region-specific hepatitis B prevalence in Turkey estimated using generalized linear mixed models: a systematic review , 2011, BMC infectious diseases.

[9]  Mehmet Koruk,et al.  Türkiye Viral Hepatit Önleme ve Kontrol Programı” “Sağlık Bakanlığı Yayın No, Ankara , 2018 .

[10]  Seyhan,et al.  HEPATITIS B, KNOWLEDGE, ATTITTUDE AND BEHAVIOR OF COIFFURES - , 2006 .

[11]  N. V. Doroshenko,et al.  Prevalence of hepatitis C virus and distribution of its genotypes in Northern Eurasia , 2005, Archives of Virology.